Primary Site >> Biliary tract Cancer

Gene >> MUC1

  • 1983
  • 1988
  • 1989
  • 1992
  • 1993
  • 1994
  • 1995
  • 1996
  • 1997
  • 1998
  • 1999
  • 2000
  • 2001
  • 2002
  • 2003
  • 2004
  • 2005
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Carcinoid tumor of the gallbladder associated with adenocarcinoma.
PMID: 6299500
Ref: Noninvasive carcinoma of the gallbladder arising in localized type adenomyomatosis.
PMID: 3376922
Ref: Carcinoid tumors of the gallbladder with adenocarcinomatous differentiation: a morphologic and immunohistochemical study.
PMID: 2756987
Ref: Simultaneous development of gallbladder and bile duct carcinomas with atypical epithelium intervention: a case report.
PMID: 2810826
Ref: Clinical evaluation of pancreatic cancer-associated mucin expressing CA19-9, CA50, Span-1, sialyl SSEA-1, and Dupan-2.
PMID: 1359630
Ref: Oncocytic differentiation in intrahepatic biliary cystadenocarcinoma.
PMID: 1369804
Ref: Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma.
PMID: 8393843
Ref: Expression of mucin core protein of mammary type in primary liver cancer.
PMID: 7523272
Ref: Pathological and immunohistochemical findings in a case of mucinous cholangiocarcinoma.
PMID: 8563941
Ref: MUC1-specific targeting immunotherapy with bispecific antibodies: inhibition of xenografted human bile duct carcinoma growth.
PMID: 8797593
Ref: Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study.
PMID: 8903378
Ref: MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients.
PMID: 9042800
Ref: Treatment strategy for patients with cystic lesions mimicking a liver tumor: a recent 10-year surgical experience in Japan.
PMID: 9637464
Ref: Effective adoptive immunotherapy by T-LAK cells retargeted with bacterial superantigen-conjugated antibody to MUC1 in xenografted severe combined immunodeficient mice.
PMID: 9661899
Ref: Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
PMID: 9829723
Ref: SEA-scFv as a bifunctional antibody: construction of a bacterial expression system and its functional analysis.
PMID: 10066451
Ref: Frequent expression of mucin core protein MUC1 in non-neoplastic gallbladder mucosa from patients with pancreaticobiliary maljunction.
PMID: 10459625
Ref: Mucin core protein expression in extrahepatic bile duct carcinoma is associated with metastases to the liver and poor prognosis.
PMID: 10570420
Ref: Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
PMID: 10573510
Ref: DF3 expression in human gallbladder carcinoma: significance for lymphatic invasion.
PMID: 10675475
Ref: Cholangioscopic findings in bile duct tumors.
PMID: 11060187
Ref: MUC1 and MUC2 expression in human gallbladder carcinoma: a clinicopathological study and relationship with prognosis.
PMID: 11295067
Ref: Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
PMID: 11350903
Ref: Expression of MUC1 and MUC2 and carbohydrate antigen Tn change during malignant transformation of biliary papillomatosis.
PMID: 11422499
Ref: Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses.
PMID: 11598251
Ref: Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.
PMID: 11710692
Ref: Mutated SEA-D227A-conjugated antibodies greatly enhance antitumor activity against MUC1-expressing bile duct carcinoma.
PMID: 11776376
Ref: A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma.
PMID: 11845258
Ref: Specific and effective targeting cancer immunotherapy with a combination of three bispecific antibodies.
PMID: 11852114
Ref: Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma.
PMID: 11920540
Ref: A long-term survivor of intrahepatic cholangiocarcinoma with lymph node metastasis: a case report.
PMID: 12110637
Ref: Primary liver cancer with dual expression of hepatocyte and bile duct epithelial markers.
PMID: 12143210
Ref: Biliary papillary neoplasm of the liver.
PMID: 12168796
Ref: Clinical outcomes and apomucin expression of intrahepatic cholangiocarcinoma according to gross morphology.
PMID: 12495310
Ref: Expression of mucins and cytokeratins in primary carcinomas of the digestive system.
PMID: 12748245
Ref: MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
PMID: 14752841
Ref: Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas.
PMID: 15071739
Ref: Gene expression profiling identifies markers of ampullary adenocarcinoma.
PMID: 15136764
Ref: Expression of epidermal growth factor receptor, apomucins, matrix metalloproteinases, and p53 in rat and human cholangiocarcinoma: appraisal of an animal model of cholangiocarcinoma.
PMID: 15213623
Ref: Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.
PMID: 15223952
Ref: Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.
PMID: 15223956
Ref: Phenotypic alterations of mucins and cytokeratins during gallbladder carcinogenesis.
PMID: 15260848
Ref: Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
PMID: 15282700
Ref: Subcellular localization of MUC1 recognized by a monoclonal antibody MY.1E12 correlates with postsurgical prognosis in differentiated-type gastric carcinomas of stage II and III.
PMID: 15492813
Ref: Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder.
PMID: 15554392
Ref: [Detection of bone marrow micrometastases in patients with gallbladder cancer].
PMID: 15743160
Ref: Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy.
PMID: 15690474
Ref: Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
PMID: 15725805
Ref: Long-term survival after curative left hepatectomy for mucin-producing cholangiocarcinoma: report of a case.
PMID: 15772801
Ref: Cytokeratin is a superior marker for detection of micrometastatic biliary tract carcinoma.
PMID: 15836844
Ref: MUC1 peptide vaccination in patients with advanced pancreas or biliary tract cancer.
PMID: 16101182
Ref: Prediction of prognosis in gallbladder carcinoma by mucin and p53 immunohistochemistry.
PMID: 16114133
Ref: Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions.
PMID: 16116640
Ref: MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma.
PMID: 16124042
Ref: Selection of tumour specific promoters for adenoviral gene therapy of cholangiocarcinoma.
PMID: 16168519
Ref: Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepa
PMID: 16360234
Ref: Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct.
PMID: 16741522
Ref: MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma.
PMID: 16857800
Ref: Undifferentiated spindle-cell carcinoma of the gallbladder: an immunohistochemical study.
PMID: 17013725
Ref: Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.
PMID: 17527078
Ref: Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance.
PMID: 17616258
Ref: Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability.
PMID: 17653761
Ref: A novel "patient-like" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines.
PMID: 18081149
Ref: Extrahepatic bile duct carcinoma with extensive intraepithelial spread: a clinicopathological study of 21 cases.
PMID: 18425077
Ref: Biliary neoplasia with extensive intraductal spread associated with liver cirrhosis: a hitherto unreported variant of biliary intraepithelial neoplasia.
PMID: 18430455
Ref: Clinicopathological features of "intraductal papillary neoplasm of the bile duct" and patient outcome after surgical resection.
PMID: 18795651
Ref: Intraductal papillary neoplasm of the bile duct associated with Clonorchis sinensis infection.
PMID: 18855009
Ref: [Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma].
PMID: 19094709
Ref: Elevation of serum KL-6 mucin levels in patients with cholangiocarcinoma.
PMID: 19260467
Ref: Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer.
PMID: 19055478
Ref: Cholangioscopy by using narrow-band imaging and transpapillary radiotherapy for mucin-producing bile duct tumor.
PMID: 19061973
Ref: Biliary intraductal papillary mucinous neoplasia: three case reports.
PMID: 19347361
Ref: Expression of KL-6 mucin, a human MUC1 mucin, in intrahepatic cholangiocarcinoma and its potential involvement in tumor cell adhesion and invasion.
PMID: 19631667
Ref: Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.
PMID: 19639217
Ref: Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.
PMID: 21160963
Ref: Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: an immunohistochemical approach.
PMID: 19680592
Ref: Immunohistochemical study of mucin expression in periampullary adenomyoma.
PMID: 19784541
Ref: Significance of mucin expression in pancreatobiliary neoplasms.
PMID: 19787286
Ref: Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
PMID: 20107918
Ref: Ampullary cancer.
PMID: 20168227
Ref: Human gallbladder carcinoma: Role of neurotrophins, MIB-1, CD34 and CA15-3.
PMID: 20353905
Ref: Surgical treatment of intrahepatic cholangiocarcinoma--a single center experience.
PMID: 20420253
Ref: Monolobar ductal plate malformation disease of the liver.
PMID: 20518892
Ref: Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma.
PMID: 20578261
Ref: Survival after pancreaticoduodenectomy for ampullary cancer is not affected by age.
PMID: 20714897
Ref: Differential gene expression profiling of cultured neu-transformed versus spontaneously-transformed rat cholangiocytes and of corresponding cholangiocarcinomas.
PMID: 20816680
Ref: The expression of MUC mucin in cholangiocarcinoma.
PMID: 20947262
Ref: Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.
PMID: 21084962
Ref: Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis.
PMID: 21106111
Ref: Hepatic nodular hamartoma containing liver cysts, ductal plate malformations and peribiliary glands.
PMID: 21199202
Ref: Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion.
PMID: 21412069
Ref: Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line GBC-SD.
PMID: 21462380
Ref: Hepatocyte nuclear factor (HNF) 4alpha expression distinguishes ampullary cancer subtypes and prognosis after resection.
PMID: 21494118
Ref: Expression of MUC1 and MUC2 in ampullary cancer.
PMID: 21700631
Ref: [A case of hilar bile duct cancer which recurred at abdominal and cervical lymph nodes 8 years after curative resection].
PMID: 21737980
Ref: Long-term survival after resection of mass-forming type intrahepatic cholangiocarcinoma directly infiltrating the transverse colon and sequential brain metastasis: Report of a case.
PMID: 21922366
Ref: Mucins differently expressed in various ampullary adenocarcinomas.
PMID: 22027009
Ref: Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis.
PMID: 22175889
Ref: Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
PMID: 22175890
Ref: Intraductal tubulopapillary neoplasm of the bile duct: potential origin from peribiliary cysts.
PMID: 21813159
Ref: Distinctive expression of CD133 between intraductal papillary neoplasms of the bile duct and bile duct adenocarcinomas.
PMID: 22221899
Ref: Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes.
PMID: 22271564
Ref: [A case of cholangiolocellular carcinoma combined with intrahepatic cholangiocarcinoma diagnosed after 4 years follow-up for hepatic hemangioma].
PMID: 22306546
Ref: Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?
PMID: 22504729
Ref: Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
PMID: 22634127
Ref: Intraductal neoplasm of the intrahepatic bile duct: clinicopathological study of 24 cases.
PMID: 22851859
Ref: Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are >/=1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
PMID: 22895264
Ref: Intrahepatic cholangiocarcinoma with predominant "ductal plate malformation" pattern: a new subtype.
PMID: 23073321
Ref: Intraductal tubular neoplasms of the bile ducts.
PMID: 23073323
Ref: Prognostic significance of muc4 expression in gallbladder carcinoma.
PMID: 23101681
Ref: Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas.
PMID: 23106580
Ref: Expression of MUC1 and MUC4 in gallbladder adenocarcinoma.
PMID: 23136569
Ref: Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules.
PMID: 23134772
Ref: Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct.
PMID: 23163606
Ref: Mucins 1-shRNA inhibit the proliferation and HIF-1alpha protein expression on human cholangiocarcinoma cells.
PMID: 23339102
Ref: WTAP regulates migration and invasion of cholangiocarcinoma cells.
PMID: 23354623
Ref: Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype.
PMID: 23573322
Ref: Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma.
PMID: 23612463
Ref: SPRR2A expression in cholangiocarcinoma increases local tumor invasiveness but prevents metastasis.
PMID: 23728799
Ref: Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer.
PMID: 23877328
Ref: Pathological aspects of so called "hilar cholangiocarcinoma".
PMID: 23919110
Ref: Clinicopathological subclassification of biliary cystic tumors: Report of 4 cases with a review of the literature.
PMID: 25343105
Ref: Cytologic features of fibrolamellar carcinoma with mucin production: a rare variant of combined hepatocellular-cholangiocarcinoma.
PMID: 23008149
Ref: Prognostic biomarkers in patients with resected cholangiocarcinoma: a systematic review and meta-analysis.
PMID: 24081803
Ref: The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.
PMID: 24832159
Ref: Histological Characterization of Biliary Intraepithelial Neoplasia with respect to Pancreatic Intraepithelial Neoplasia.
PMID: 24860672
Ref: Histopathological and immunophenotypical features of intestinal-type adenocarcinoma of the gallbladder and its precursors.
PMID: 24955710
Ref: Tubulin beta-III: a novel immunohistochemical marker for intrahepatic peripheral cholangiocarcinoma.
PMID: 25039376
Ref: A case of mixed adenoneuroendocrine carcinoma of the gallbladder arising from an intracystic papillary neoplasm associated with pancreaticobiliary maljunction.
PMID: 25146100
Ref: Signet ring cell carcinoma of the ampulla of Vater: Immunophenotype and differentiation.
PMID: 25202392
Ref: Histological phenotype is correlated with the wall-invasion pattern of gallbladder adenocarcinoma.
PMID: 25355436
Ref: Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases.
PMID: 26111977
Ref: Matrix metalloproteinase 7 expression in ampullary carcinoma.
PMID: 26275245
Ref: Clinical and pathological features of intraductal papillary neoplasm of the biliary tract and gallbladder.
PMID: 26278323
Ref: Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer.
PMID: 26416714
Ref: Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups.
PMID: 26500334
Ref: Expression of Molecular Differentiation Markers Does Not Correlate with Histological Differentiation Grade in Intrahepatic Cholangiocarcinoma.
PMID: 27280413
Ref: Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
PMID: 27688085
Ref: Apical membrane expression of distinct sulfated glycans represents a novel marker of cholangiolocellular carcinoma.
PMID: 27748735
Ref: Mucins in neoplasms of pancreas, ampulla of Vater and biliary system.
PMID: 27795812
Ref: Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
PMID: 27358229
Ref: Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.
PMID: 27739441
Ref: Gallbladder papillary neoplasms share pathological features with intraductal papillary neoplasm of the bile duct.
PMID: 28415560
Ref: Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
PMID: 28505002
Ref: Clinicopathological Study of Carcinoma of the Ampulla of Vater with Special Reference to MUC1, MUC2 and MUC5AC Expression.
PMID: 28658766
Ref: Immunohistochemical Study of MUC1 and MUC5AC Expression in Gall Bladder Lesions.
PMID: 28892903
Ref: Immunohistochemical Comparison of Malignancy Between Radial Invasion and Mucosal Extension in Hilar Cholangiocarcinoma.
PMID: 28982905
Ref: Intrahepatic cholangiocarcinoma after Fontan procedure in an adult with visceral heterotaxy.
PMID: 29559246
Ref: Mucinous intrahepatic cholangiocarcinoma: a distinct variant.
PMID: 29698701
Ref: Fairly rare clear cell adenocarcinoma mimicking liver cancer: a case report.
PMID: 30117003
Ref: Rationale and feasibility of mucin expression profiling by qRT-PCR as diagnostic biomarkers in cytology specimens of pancreatic cancer.
PMID: 30268674